Home » Topics » BioWorld Science

BioWorld Science
RSS

Zymeworks and Daiichi Sankyo expand immuno-oncology collaboration

May 15, 2018

Medisix Therapeutics closes series A financing

May 15, 2018

Researchers develop PXDN-mutant microphthalmia and dysgenesis murine model

May 15, 2018

FDA accepts for review BLA for pegfilgrastim biosimilar CHS-1701

May 15, 2018

Soleno Therapeutics initiates phase III study of DCCR in Prader-Willi syndrome

May 15, 2018

Lymph-directed compound ST-182 simultaneously inhibits MAPK, PI3K and mTOR

May 15, 2018

Galectin proceeds with plans for phase III program with GR-MD-02 in NASH cirrhosis

May 15, 2018

New ELMO3 gene mutation tied to keratoconus

May 15, 2018

Researchers at Ben-Gurion University develop a novel molecule for the treatment of cancer

May 15, 2018

Search for small-molecule PD-1/PD-L1 inhibitors yields JBI-426

May 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...